We are live on ! Find out more
BKYI

BIO-key International
BKYI

5 hedge funds and large institutions have $264K invested in BIO-key International in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

25% more funds holding

Funds holding: 4 → 5 (+1)

0% less ownership

Funds ownership: 0% → 0% (-0%)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

59% less capital invested

Capital invested by funds: $644K → $264K (-$380K)

Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
+$25.2K
2
Renaissance Technologies
Renaissance Technologies
New York
+$25.2K
3
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
+$16.8K

Top Sellers

Rank Fund Capital Flow
1
PCM
Perkins Capital Management
Minnesota
-$132K
2
Millennium Management
Millennium Management
New York
-$50.4K
3
Goldman Sachs
Goldman Sachs
New York
-$48K

BKYI Hedge Fund Activity: Q4 2017 in Review

5 of the 4,418 institutional investors tracked by Wall St. Rank reported a position in BIO-key International (BKYI) for Q4 2017, worth a combined $264K — down 59% from $644K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new BKYI positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Deutsche Bank, opening a new position worth an estimated $25.2K. The largest seller was Perkins Capital Management, cutting an estimated $132K.

  • 5 institutional investors held BIO-key International (BKYI) as of Q4 2017, up from 4 in Q3 2017.
  • Funds reported $264K of BIO-key International stock for Q4 2017, down 59% quarter-over-quarter.
  • 2 funds opened new BIO-key International positions in Q4 2017 and 1 closed out, a net change of +1 holder.
  • The largest BIO-key International buyer in Q4 2017 was Deutsche Bank, an estimated $25.2K added.
  • The largest BIO-key International seller in Q4 2017 was Perkins Capital Management, an estimated $132K sold.

Based on aggregated 13F filings for Q4 2017.